We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 165

Privacy & cybersecurity update, issue 3 - October, 2014
  • Jones Day
  • Australia, Brazil, New Zealand, Russia, Taiwan, USA, Hong Kong, Ireland, Italy, Japan, Mexico, Netherlands, Canada, Chile, China, European Union, France, Germany
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to


A “double Irish” for life sciences companies
  • Arnall Golden Gregory LLP
  • Ireland, USA
  • March 18 2014

Many U.S. life sciences are basing their international operations and tax structure in Ireland. We continue to receive such inquiries from clients


User fees for generic drugs - what are the issues?
  • Sheppard Mullin Richter & Hampton LLP
  • Ireland, USA
  • August 30 2010

On August 9, 2010, the Food and Drug Administration ("FDA") published a notice announcing a public meeting to be held September 17, 2010, "to gather stakeholder input on the development of a generic drug user fee program."


Impact of the temporary agency workers directive on the healthcare sector
  • Mason Hayes & Curran
  • Ireland, USA
  • September 12 2011

HSE Management who engage agency workers to cover a short-term need, such as an upturn in hospital admissions, sickness, absence or maternity leave, should be aware of the potentially far-reaching consequences of the Temporary Agency Workers Directive (the “Directive”


Brian McDermott
  • A&L Goodbody

Paula Mullooly
  • A&L Goodbody

Kevin Allen
  • A&L Goodbody

Katrina Evans
  • King & Wood Mallesons

James Grennan
  • A&L Goodbody

Tamara Hunter
  • King & Wood Mallesons